Combined Simvastatin and Irinotecan in Treating ES-SCLC Patients Relapsed From 1st Chemotherapy
Condition: Small Cell Lung Cancer Interventions: Drug: Irinotecan; Drug: Simvastatin Sponsors: Shanghai Pulmonary Hospital, Shanghai, China; Chinese Academy of Sciences Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 2, 2021 Category: Research Source Type: clinical trials